Antibody treatments for cancer and other diseases are typically delivered intravenously, because of the large volumes that are needed per dose. This means the patient has to go to a hospital for every ...
After a series of unfortunate regulatory rejections and manufacturing issues surfaced, Regeneron’s shares dipped to $483 this ...
The pharmaceutical supply chain and device development have become intricately linked. Harmonizing formulation development ...
The Buckland Group launched Quvara Medical as the newest CDMO to debut this year after buying a former Becton Dickinson manufacturing site in the U.K. for an undisclosed price. | The Buckland Group ...
Integrated isolators, sterilization technologies, and filling solutions deliver proven sterility, reliability, and efficiency ...
The global slip-tip syringe market is entering a phase of dynamic growth, as both long-standing manufacturers and a new ...
The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.
Macter International Limited announced on Thursday that it had obtained the requisite licenses for its Pre-Filled Syringe (PFS) and Pre-Filled Pen (PFP) manufacturing facilities within its biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback